# Medpace Holdings Prepares to Report Q3 Earnings as Revenue Growth Is Expected to Slow

- URL: https://stocks.freetheai.org/news/medpace-holdings-prepares-to-report-q3-earnings-as-revenue-growth-is-expected-to-56f35d
- Published: 2026-10-20T03:11:37Z
- Category: earnings; sentiment: neutral; impact: medium
- Symbols: [NASDAQ:MEDP](https://stocks.freetheai.org/symbols/NASDAQ-MEDP)
- Written by our AI from expert market sources across the web for FreeTheAI Stocks, built by Vibhek Soni
- How write-ups are made: https://stocks.freetheai.org/how-we-write
- Not financial advice: https://stocks.freetheai.org/disclaimer

Clinical research firm Medpace Holdings, Inc. (NASDAQ:MEDP) is set to release its third-quarter financial results this Wednesday after market close. Wall Street consensus projections call for quarterly revenue growth of 8.1% year over year. That represents a deceleration compared to the 23.7% revenue expansion recorded during the prior-year period, though analysts have largely kept their estimates steady over the past month. The stock traded slightly higher at $619.70, up 0.19% on the day.

The upcoming report follows a solid second quarter in which Medpace generated $707.3 million in revenue, a 17.2% increase from a year earlier that topped expectations. That performance was accompanied by upgraded full-year guidance for both total sales and earnings per share. While growth is projected to moderate this quarter, Medpace has established a strong record of meeting or exceeding quarterly revenue forecasts.

Investors will be watching closely to see if the company can maintain its track record, as Medpace is the first among life sciences tools and services providers to report earnings this season. Share prices across the sector have remained virtually flat over the past month, making Medpace's performance a key indicator for broader sentiment in the segment.

## Key points

- Medpace Holdings, Inc. (NASDAQ:MEDP) will report third-quarter earnings this Wednesday after the market closes.
- Analysts expect third-quarter revenue growth of 8.1% year over year, down from 23.7% growth in the prior-year period.
- The company beat second-quarter revenue forecasts with $707.3 million in sales, up 17.2% year over year.
- Medpace is the first life sciences tools and services firm to report earnings this quarter, serving as an early benchmark for the sector.

## Questions and answers

### When is Medpace Holdings reporting its Q3 earnings?

Medpace Holdings is scheduled to announce its third-quarter earnings results this Wednesday after the market closes.

### What are analysts expecting for Medpace's Q3 revenue growth?

Analysts expect Medpace's revenue to grow by 8.1% year over year in the third quarter, a slowdown from the 23.7% growth reported in the same period last year.

### How did Medpace perform in its previous quarterly earnings report?

In the second quarter, Medpace reported revenue of $707.3 million, up 17.2% year over year, beating analyst expectations and raising its full-year revenue and EPS guidance.